RU2005127888A - METHOD FOR OBTAINING HUMAN GENERAL GENERAL OBSTRUCIUM CHEMISTRINE - Google Patents
METHOD FOR OBTAINING HUMAN GENERAL GENERAL OBSTRUCIUM CHEMISTRINE Download PDFInfo
- Publication number
- RU2005127888A RU2005127888A RU2005127888/13A RU2005127888A RU2005127888A RU 2005127888 A RU2005127888 A RU 2005127888A RU 2005127888/13 A RU2005127888/13 A RU 2005127888/13A RU 2005127888 A RU2005127888 A RU 2005127888A RU 2005127888 A RU2005127888 A RU 2005127888A
- Authority
- RU
- Russia
- Prior art keywords
- cells
- escherichia coli
- per
- human glucagon
- strain
- Prior art date
Links
- 210000004027 cell Anatomy 0.000 claims 7
- 241000588724 Escherichia coli Species 0.000 claims 6
- 101500028775 Homo sapiens Glucagon Proteins 0.000 claims 5
- 239000013612 plasmid Substances 0.000 claims 5
- 238000002955 isolation Methods 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 239000012634 fragment Substances 0.000 claims 2
- 230000017730 intein-mediated protein splicing Effects 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000204 Dipeptidase 1 Proteins 0.000 claims 1
- 102000051325 Glucagon Human genes 0.000 claims 1
- 108060003199 Glucagon Proteins 0.000 claims 1
- 229930182555 Penicillin Natural products 0.000 claims 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 239000007853 buffer solution Substances 0.000 claims 1
- 239000004202 carbamide Substances 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 230000029087 digestion Effects 0.000 claims 1
- 238000007865 diluting Methods 0.000 claims 1
- 239000013613 expression plasmid Substances 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 230000002068 genetic effect Effects 0.000 claims 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 claims 1
- 229960004666 glucagon Drugs 0.000 claims 1
- 210000003000 inclusion body Anatomy 0.000 claims 1
- 238000011534 incubation Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 229940049954 penicillin Drugs 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 108091008146 restriction endonucleases Proteins 0.000 claims 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 230000009466 transformation Effects 0.000 claims 1
- 230000001131 transforming effect Effects 0.000 claims 1
- 238000002604 ultrasonography Methods 0.000 claims 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2005127888/13A RU2302465C2 (en) | 2005-09-07 | 2005-09-07 | METHOD FOR PRODUCTION OF HUMAN GENE ENGINEERED GLUCAGONE, RECOMBINANT PLASMIDE DNA pER-Gl, ENCODING AUTOCATALITICALLY CLEAVABLE HYBRID PROTEIN FORMING HUMAN GLUCAGONE AND STRAIN OF Escherichia coli ER-2566/pER-Gl AS PRODUCER OF SAID PROTEIN |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2005127888/13A RU2302465C2 (en) | 2005-09-07 | 2005-09-07 | METHOD FOR PRODUCTION OF HUMAN GENE ENGINEERED GLUCAGONE, RECOMBINANT PLASMIDE DNA pER-Gl, ENCODING AUTOCATALITICALLY CLEAVABLE HYBRID PROTEIN FORMING HUMAN GLUCAGONE AND STRAIN OF Escherichia coli ER-2566/pER-Gl AS PRODUCER OF SAID PROTEIN |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2005127888A true RU2005127888A (en) | 2007-03-20 |
| RU2302465C2 RU2302465C2 (en) | 2007-07-10 |
Family
ID=37993687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2005127888/13A RU2302465C2 (en) | 2005-09-07 | 2005-09-07 | METHOD FOR PRODUCTION OF HUMAN GENE ENGINEERED GLUCAGONE, RECOMBINANT PLASMIDE DNA pER-Gl, ENCODING AUTOCATALITICALLY CLEAVABLE HYBRID PROTEIN FORMING HUMAN GLUCAGONE AND STRAIN OF Escherichia coli ER-2566/pER-Gl AS PRODUCER OF SAID PROTEIN |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2302465C2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2642260C1 (en) * | 2016-10-21 | 2018-01-24 | Федеральное государственное бюджетное учреждение "Государственный научно-исследовательский институт генетики и селекции промышленных микроорганизмов Национального исследовательского центра "Курчатовский институт" (НИЦ "Курчатовский институт" - ГосНИИгенетика) | Polypeptide for blood sugar level reducing on basis of human glucagon-like peptide-1, recombinant producing strain e. coli and method of obtaining this polypeptide |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3254692B2 (en) * | 1991-09-04 | 2002-02-12 | 松下電器産業株式会社 | Air conditioner wind direction control method |
| FI20021726A0 (en) * | 2002-09-27 | 2002-09-27 | Ctt Cancer Targeting Tech Oy | Process for producing peptides |
-
2005
- 2005-09-07 RU RU2005127888/13A patent/RU2302465C2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2302465C2 (en) | 2007-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106497897A (en) | A kind of engineered strain construction method for improving Heparinase I activity | |
| Wang et al. | High level expression and purification of bioactive human α-defensin 5 mature peptide in Pichia pastoris | |
| CN103509814B (en) | A kind of recombinant expression method of grass carp tumor necrosis factor alpha gene | |
| CN120699947A (en) | Artificially designed penicillin G acylase, encoding nucleotide and application thereof | |
| CN101319216A (en) | Production and purification method of recombinant silkworm antimicrobial peptide CM4 | |
| CN104342445A (en) | Vector for efficiently secreting and expressing heterogenous protein, and its application | |
| CN1111602C (en) | A method for promoting protein secretion using molecular chaperones | |
| RU2005127888A (en) | METHOD FOR OBTAINING HUMAN GENERAL GENERAL OBSTRUCIUM CHEMISTRINE | |
| CN113234132B (en) | A kind of Scylla simulans C-type lectin and its preparation method and application | |
| CN103397038B (en) | Production method of human interleukin-38 | |
| WO2008073688A3 (en) | Improved expression system for recombinant human arginase i | |
| WO2025055767A1 (en) | Method for purifying protein | |
| RU2453604C1 (en) | Hybrid protein (versions), bacterial strain escherichia coli - hybrid protein producer (versions) and method for producing methionine-free human interferon alpha-2 | |
| CN103012578B (en) | Recombinant porcine interleukin 2, and encoding gene and expression method thereof | |
| BRPI0807661A2 (en) | MODIFIED MICROORGANISM | |
| RU2441072C1 (en) | FUSION PROTEIN, ESCHERICHIA COLI STRAIN BEING FUSION PROTEIN PRODUCER AND METHOD FOR PRODUCING METHIONINE-FREE HUMAN INTERFERON ALPHA-2b OF SUCH FUSION PROTEIN | |
| RU2316590C1 (en) | RECOMBINANT PLASMID DNA pE-His8-TrxL-Ar2 ENCODING FUSION PROTEIN COMPRISING ANTIMICROBIAL SEA ANNELID WORM Arenicola marina PEPTIDE ARENICIN AND STRAIN Escherichia coli BL21(DE3)/pE-His8-TrxL-Ar2 AS PRODUCER OF ARENICIN-CONTAINING FUSION PROTEIN | |
| Wang et al. | High-level production of biologically active chemokines in Escherichia Coli | |
| RU2009139153A (en) | Recombinant plasmid DNA pER-Hir, encode fusion protein capable of autocatalytic cleavage with formation [Leu1, Thr2] -63-DESULFATOGIRUDINA strain Escherichia coli ER2566 / pER-Hir-PRODUCER said proteins and methods for producing genetically engineered [Leu1, Thr2] -63-DESULFATOGURUDIN | |
| RU2839376C1 (en) | PLASMID GENETIC CONSTRUCT pET21a_SKP, WHICH PROVIDES EXPRESSION IN ESCHERICHIA COLI PROKARYOTIC SYSTEM OF RECOMBINANT SKP PROTEIN, AND RECOMBINANT PROTEIN SKP HAVING BROADLY NEUTRALIZING PROPERTIES OF SINGLE-DOMAIN NANOANTIBODY AGAINST SARS-CoV-2 | |
| RU2011142855A (en) | Recombinant plasmid DNA pPA-OPRFI, encodes the synthesis of a fusion recombinant protein F-I outer membrane PSEUDOMONAS AERUGINOSA, STRAIN ESCHERICHIA COLI PA-OPRFI-PRODUCER HYBRID RECOMBINANT PROTEIN F-I outer membrane PSEUDOMONAS AERUGINOSA, AND METHOD FOR PRODUCING HYBRID RECOMBINANT PROTEIN F-I outer membrane PSEUDOMONAS AERUGINOSA | |
| CN116855486B (en) | Streptococcus prophage lyase lys1644 and application thereof | |
| CN116284275B (en) | Intrapeptide Ssp tau, its encoding gene and its application in the preparation of tetrapeptide-5 | |
| RU2007139262A (en) | Recombinant plasmid pHINS21, encoding a hybrid protein with human pro-insulin, a strain of Escherichia coli bacteria JM109 / pHINS21 - producer of pro-granulose-white hyalurum | |
| RU2006118439A (en) | Process for the preparation of genetically engineered HUMAN EPIDERMAL GROWTH FACTOR, with recombinant plasmid DNA pER-hEGF, encode fusion protein capable of autocatalytic cleavage WITH FORMATION OF HUMAN EPIDERMAL GROWTH FACTOR AND STRAIN Escherichia coli ER2566 / pER-hEGF - PRODUCER said protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20160908 |